Variant report
Variant | esv3374931 |
---|---|
Chromosome Location | chr7:112857766-112859764 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185911766 | chr7:112857831-112857832 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536659351 | chr7:112857842-112857843 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190780230 | chr7:112857860-112857861 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183021915 | chr7:112857893-112857894 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187707979 | chr7:112857977-112857978 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552738553 | chr7:112857988-112857989 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191007773 | chr7:112857990-112857991 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78456966 | chr7:112857992-112857993 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566912122 | chr7:112857999-112858000 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28638771 | chr7:112858035-112858036 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs530388774 | chr7:112858046-112858047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182786592 | chr7:112858047-112858048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534245167 | chr7:112858074-112858075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560893605 | chr7:112858087-112858088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528176771 | chr7:112858099-112858100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555920231 | chr7:112858156-112858157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78363786 | chr7:112858157-112858158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532746404 | chr7:112858162-112858163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550952976 | chr7:112858170-112858171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529956206 | chr7:112858174-112858175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79554107 | chr7:112858175-112858176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569549896 | chr7:112858182-112858183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536225523 | chr7:112858214-112858215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554523131 | chr7:112858328-112858329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566566910 | chr7:112858374-112858375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534023785 | chr7:112858388-112858389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540559223 | chr7:112858389-112858390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558628895 | chr7:112858430-112858431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13235584 | chr7:112858451-112858452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13222761 | chr7:112858452-112858453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577722899 | chr7:112858485-112858486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545201344 | chr7:112858493-112858494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187435564 | chr7:112858507-112858508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575473097 | chr7:112858510-112858511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192833651 | chr7:112858566-112858567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71544736 | chr7:112858568-112858569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1852193 | chr7:112858570-112858571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112882388 | chr7:112858572-112858573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375607821 | chr7:112858576-112858577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540286950 | chr7:112858578-112858579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs564984153 | chr7:112858581-112858582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56325958 | chr7:112858582-112858583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs55679607 | chr7:112858584-112858585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368958237 | chr7:112858632-112858633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1608880 | chr7:112858634-112858635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55716070 | chr7:112858653-112858654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs60525262 | chr7:112858655-112858656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532562876 | chr7:112858675-112858676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs36132049 | chr7:112858679-112858680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1852194 | chr7:112858684-112858685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:112857200-112858200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:112857600-112858000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:112858000-112858200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr7:112858200-112859000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr7:112858200-112859600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |